EU approves Roche’s Actemra for severe COVID-19The European Commission has moved swiftly to grant full approval to Roche’s Actemra/RoActemra as a treatment for severe Share XEU approves Roche’s Actemra for severe COVID-19https://pharmaphorum.com/news/eu-approves-roches-actemra-for-covid-19/
Actemra shortage spills over to include Sanofi’s rival KevzaraRoche’s Actemra has been in high demand since its value in treating severe COVID-19 was established, leading to Share XActemra shortage spills over to include Sanofi’s rival Kevzarahttps://pharmaphorum.com/news/actemra-shortage-spills-over-to-include-sanofis-rival-kevzara/
Amid Actemra shortage, WHO asks Roche to ensure equitable accessRoche’s arthritis drug Actemra has become a key treatment for people with severe COVID-19, leading to shortages, and Share XAmid Actemra shortage, WHO asks Roche to ensure equitable accesshttps://pharmaphorum.com/news/amid-actemra-shortage-who-asks-roche-to-ensure-equitable-access/
FDA gives Roche’s Actemra emergency okay for severe COVIDRoche has been granted emergency approval by the FDA for its arthritis drug Actemra as a treatment for Share XFDA gives Roche’s Actemra emergency okay for severe COVIDhttps://pharmaphorum.com/news/fda-gives-roches-actemra-emergency-okay-for-severe-covid/
IL-6 drugs do work in COVID-19, says UK, as it plans NHS useNew data means that IL-6 drugs from Roche and Sanofi that had been all-but written off as coronavirus Share XIL-6 drugs do work in COVID-19, says UK, as it plans NHS usehttps://pharmaphorum.com/news/il-6-drugs-covid-19-new-trial/
Roche’s Actemra cuts chances of COVID-19 ventilator use in phase 3 trialRoche’s Actemra may help fight pandemic after all with phase 3 trial results showing it cut the chances Share XRoche’s Actemra cuts chances of COVID-19 ventilator use in phase 3 trialhttps://pharmaphorum.com/news/roche-actemra-cuts-chances-of-covid-19/
Setback in COVID-19 effort as Roche’s Actemra fails in key trialRoche’s anti-inflammatory drug Actemra has failed in a phase 3 clinical trial that was testing to see if Share XSetback in COVID-19 effort as Roche’s Actemra fails in key trialhttps://pharmaphorum.com/news/setback-in-covid-19-effort-as-roches-actemra-fails-in-key-trial/
COVID-19 candidate Actemra helps Roche to solid first quarterRoche shrugged off the impact of the coronavirus pandemic in the first-quarter with good sales growth across its Share XCOVID-19 candidate Actemra helps Roche to solid first quarterhttps://pharmaphorum.com/news/covid-19-candidate-actemra-helps-roche-to-solid-first-quarter/
Roche begins phase 3 trial of Actemra in COVID-19 pneumoniaRoche is to begin a phase 3 trial of its Actemra/RoActemra as a treatment for patients hospitalised with Share XRoche begins phase 3 trial of Actemra in COVID-19 pneumoniahttps://pharmaphorum.com/news/roche-begins-phase-3-trial-of-actemra-in-covid-19-pneumonia/
